Fig. 6From: An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapyResults of immune signatures analysis performed by ImSig. The boxplots (A and B) show the gene expression of T and NK signature genes (estimated relative abundance) across the HM, non-HM and HM-like groups. Statistical analysis of data was performed using analysis of variance (ANOVA) followed by multiple comparison Tukey’s test. **P < .01, *P < .05Back to article page